CMET-16. A PHASE II TRIAL OF BEVACIZUMAB IN PATIENTS WITH RECURRENT SOLID TUMOR BRAIN METASTASES WHO HAVE PROGRESSED FOLLOWING WHOLE BRAIN RADIATION THERAPY (WBRT): FINAL RESULTS

BACKGROUND: Brain metastases (BM) are the most common intracranial tumor with limited treatment options following the progression after WBRT. METHODS: This open label phase 2 study for patients have progressed following WBRT enrolled participants who received bevacizumab 10 mg/kg intravenously every...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Kumthekar, Priya, Dixit, Karan, Grimm, Sean, Lukas, Rimas, Schwartz, Margaret, Helenowski, Irene, Sharp, Laura, Nelson, Valerie, Raizer, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
CNS Metastasis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847740/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados